Endoscopic Surveillance and Dysplasia Management in IBD: Plus Ça Change, Plus C'est la Même Chose
暂无分享,去创建一个
[1] G. Nguyen,et al. AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. , 2021, Gastroenterology.
[2] Seth D. Crockett,et al. AGA Clinical Practice Update on Strategies to Improve Quality of Screening and Surveillance Colonoscopy: Expert Review. , 2021, Gastroenterology.
[3] J. Feuerstein,et al. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments , 2019, World journal of gastroenterology.
[4] Alan Barkun,et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastrointestinal endoscopy.
[5] A. Barkun,et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. , 2015, Gastroenterology.
[6] Hans Clevers,et al. At the Crossroads of Inflammation and Cancer , 2004, Cell.
[7] C. Bernstein,et al. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.
[8] E. Finlayson,et al. Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary? , 2017, Gastroenterology.
[9] R. McLeod,et al. Position Statement on the Diagnosis and Management of olorectal Neoplasia in Inflammatory Bowel Disease , 2022 .